share_log

HC Wainwright & Co. Reiterates Buy on IO Biotech, Lowers Price Target to $8

Benzinga ·  Aug 11, 2023 13:12

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and lowers the price target from $11 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment